Type 2 Diabetes Market Insights, Epidemiology, and Market Forecast 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key type 2 diabetes companies, including Sanofi, Eli Lilly and Company, AstraZeneca, Novartis, among others
In my years of medical practice, Ive never seen a class of medications gain as much attention in both medical and cultural spheres as GLP-1 agonists
further hypothesized that individuals with upstream mutations to POMC, resulting in reduced amounts of endogenous MC agonists, are more responsive to exogenous agonists compared to those with a functional MC pathway (86)
What we found was that the average weight loss was about 5% with a GLP-1 agonist and that the longer patients were on the GLP-1 agonist, the more weight they tended to lose
The frequency of nausea in both groups peaked at week one and gradually declined thereafter